Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JNJ-18038683 in Major Depressive Disorder
NCT00566202Phase 2Completed
- Sponsor
- Johnson & Johnson
- Start
- Dec 2007
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of JNJ-18038683 in major depressive disorder (MDD), sponsored by Johnson & Johnson. Started Dec 2007; status: completed.
02
Drugs
JNJ-18038683
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00566202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00566202.